Bio-outsourcing

Agilent splits up to create two separate businesses

Agilent splits up to create two separate businesses

Agilent Technologies has officially separated its biopharma service offerings from its electric measurement group to create two separate companies, the life science portion of which is expected to bring in about $3.9B in FY2013.

CST Unveils HER3 Rabbit mAb for Researchers

CST Unveils HER3 Rabbit mAb for Researchers

By Zachary Brennan

Cell Signaling Technology launched a new HER3 rabbit monoclonal antibody (mAb) for researchers studying HER2-mediated breast, lung and ovarian tumors. 

GSK Launches $50M ‘Electroceuticals’ Venture Capital Fund

GSK Launches $50M ‘Electroceuticals’ Venture Capital Fund

By Zachary Brennan

GlaxoSmithKline is gambling $50M on a venture capital fund that will invest in 20 projects that pioneer bioelectric drugs and technologies that aim to target individual nerve fibres or specific brain circuits to treat an array of conditions.

Follow us

Product Innovations